This activity includes animated videos.
This activity includes a Pocket Pharmacist guide.
Program Description
In recent years, the most significant advances that have been made in the treatment of cancer is the development of non-conventional chemotherapy treatment options known as immuno-oncology, specifically the rapidly expanding use of immune checkpoint inhibitors (ICIs). Maintaining a practical working knowledge of the evolving immuno-oncology landscape and its implications in therapy can enhance the care community pharmacists provide to patients with cancer, and it is important that they understand the unique toxicities of these treatments. Pharmacists must be informed about recently expanded and investigational indications of ICIs to best counsel patients and assist providers in improving adherence and treatment outcomes in patients receiving ICI therapies. This program features video animations that will highlight the mechanism of action of ICIs in the treatment and management of different malignancies as well as strategies for pharmacists to appropriately manage immune-related adverse events.
Target audience: Retail pharmacists
Type of activity: Application
Release date: November 30, 2022
Expiration date: November 30, 2023
Time to complete activity: 1.25 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify the various mechanisms of action of FDA-approved immune checkpoint inhibitors (ICIs) and how they work as monotherapy and in synergy with other agents to treat cancer
- Explore FDA-approved indications as well as safety and efficacy data for ICIs in cancer treatment
- Distinguish immune-related adverse effects of ICIs from toxicities of traditional cytotoxic chemotherapy
- Apply special considerations for patients receiving ICI therapies to the safe and effective provision of preventive care, supportive care, and toxicity management in the community pharmacy setting
Jacob K. Kettle, PharmD, BCOP
Director, Ellis Fischel Cancer Center
University of Missouri Health Care
Columbia, Missouri
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.25 contact hours (0.125 CEU) under the ACPE universal activity number 0290-0000-22-597-H01-P. The activity is available for CE credit through November 30, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Jacob K. Kettle, PharmD, BCOP, has the following financial relationships with commercial interests to disclose:
Consultant: Urogen, Genentech, Merck
Speakers Bureau: Amgen, Genentech, DSI
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; MBA; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no financial relationships with commercial interests to disclose.
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms